HUP0401696A2 - Angiotenzin-II receptor antagonistát tartalmazó gyógyászati készítmény - Google Patents

Angiotenzin-II receptor antagonistát tartalmazó gyógyászati készítmény

Info

Publication number
HUP0401696A2
HUP0401696A2 HU0401696A HUP0401696A HUP0401696A2 HU P0401696 A2 HUP0401696 A2 HU P0401696A2 HU 0401696 A HU0401696 A HU 0401696A HU P0401696 A HUP0401696 A HU P0401696A HU P0401696 A2 HUP0401696 A2 HU P0401696A2
Authority
HU
Hungary
Prior art keywords
receptor antagonist
compositions containing
angiotensin
medicinal compositions
containing angiotensin
Prior art date
Application number
HU0401696A
Other languages
English (en)
Inventor
Toshio Sada
Toshimori Inaba
Original Assignee
Sankyo Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co., Ltd. filed Critical Sankyo Co., Ltd.
Publication of HUP0401696A2 publication Critical patent/HUP0401696A2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A jelen találmány tárgya gyógyászati készítmény angiotenzin-IIreceptor antagonista és ACAT-gátló egyidejű, különálló, történő vagyegymást követő adagolására. A találmány tárgyát képezi továbbáangiotenzin-II receptor antagonista ACAT-gátlóval való alkalmazásaegyidejűleg, különállóan vagy egymást követően adagolandó gyógyszerelőállítására, amely arterioszklerózis és/vagy isémiás szívbetegségmegelőzésére vagy kezelésére szolgál melegvérű állatban. Ó
HU0401696A 2001-08-28 2002-08-27 Angiotenzin-II receptor antagonistát tartalmazó gyógyászati készítmény HUP0401696A2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001257435 2001-08-28
PCT/JP2002/008629 WO2003020315A1 (fr) 2001-08-28 2002-08-27 Compositions medicinales contenant un antagoniste du recepteur d'angiotensine ii

Publications (1)

Publication Number Publication Date
HUP0401696A2 true HUP0401696A2 (hu) 2004-11-29

Family

ID=19085097

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0401696A HUP0401696A2 (hu) 2001-08-28 2002-08-27 Angiotenzin-II receptor antagonistát tartalmazó gyógyászati készítmény

Country Status (17)

Country Link
US (1) US20040198788A1 (hu)
EP (1) EP1421953A4 (hu)
KR (1) KR20040032969A (hu)
CN (1) CN1589154A (hu)
AU (1) AU2002328569B9 (hu)
BR (1) BR0212254A (hu)
CA (1) CA2459017A1 (hu)
CO (1) CO5560583A2 (hu)
HU (1) HUP0401696A2 (hu)
IL (1) IL160438A0 (hu)
MX (1) MXPA04001878A (hu)
NO (1) NO20041291L (hu)
NZ (1) NZ531346A (hu)
PL (1) PL368843A1 (hu)
RU (1) RU2004105965A (hu)
WO (1) WO2003020315A1 (hu)
ZA (1) ZA200401603B (hu)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0406987A (pt) * 2003-01-31 2006-01-10 Sankyo Co Medicamento para a prevenção e/ou tratamento de arteriosclerose, medicamentos para a inibição de proliferação de células do músculo liso vascular, de formação de neoìntima dos vasos sanguìneos e de remodelação vascular, medicamento para a prevenção de restenose que segue intervenção coronária percutânea, e, medicamentos para a profilaxia e/ou tratamento de hipertensão ou doenças causadas por hipertensão ou doenças causadas por hipertensão, de doenças cardìacas, de angina do peito, de infarto miocárdico, de arritmia, de morte súbita, de insuficiência cardìaca, de hipertrofia cardìaca, de doenças renais, de nefropatia diabética, de glomerulonefrite, de nefrosclerose, de doenças cerebrovasculares, de infarto cerebral, e de hemorragia cerebral
WO2007086980A2 (en) * 2005-11-10 2007-08-02 Duke University Methods of determining the risk of developing coronary artery disease
KR101345876B1 (ko) * 2012-01-31 2013-12-30 인제대학교 산학협력단 피마사르탄을 함유하는 세포, 조직 또는 장기 보존용 조성물
CN112979617A (zh) * 2019-12-17 2021-06-18 中国科学院苏州纳米技术与纳米仿生研究所 一种厄贝沙坦哌嗪盐及其制备方法和应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4771072A (en) * 1985-01-10 1988-09-13 Tanabe Seiyaku Co., Ltd. Alkoxynaphthalene derivatives
US5138069A (en) * 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
US5120738A (en) * 1989-10-06 1992-06-09 Fujirebio Inc. Pantothenic acid derivatives
DE59107440D1 (de) * 1990-02-19 1996-04-04 Ciba Geigy Ag Acylverbindungen
US5196444A (en) * 1990-04-27 1993-03-23 Takeda Chemical Industries, Ltd. 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
GB9025509D0 (en) * 1990-11-23 1991-01-09 Fujisawa Pharmaceutical Co New amide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
ATE137744T1 (de) * 1990-11-26 1996-05-15 Taisho Pharmaceutical Co Ltd Anilidderivat
US5591762A (en) * 1991-02-06 1997-01-07 Dr. Karl Thomae Gmbh Benzimidazoles useful as angiotensin-11 antagonists
CA2061607C (en) * 1991-02-21 1999-01-19 Hiroaki Yanagisawa 1-biphenylimidazole derivatives, their preparation and their therapeutic use
US5491172A (en) * 1993-05-14 1996-02-13 Warner-Lambert Company N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents
JP3720395B2 (ja) * 1994-09-20 2005-11-24 京都薬品工業株式会社 新規ヘテロ環誘導体、その製造方法およびその医薬用途
DK0866059T3 (da) * 1995-10-05 2002-03-25 Kyoto Pharma Ind Nye heterocykliske derivater og medicinsk anvendelse deraf
FR2741619B1 (fr) * 1995-11-28 1998-02-13 Pf Medicament Nouveaux derives de 2,3,5-trimethyl-4-hydroxy-anilides, leur preparation et leur application en therapeutique
CA2197364A1 (en) * 1996-02-15 1997-08-16 Toshikazu Suzuki Phenol compound and process for preparing the same
JPH11228416A (ja) * 1997-10-23 1999-08-24 Takeda Chem Ind Ltd 脂質低下剤
US6221897B1 (en) * 1998-06-10 2001-04-24 Aventis Pharma Deutschland Gmbh Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
DE19916108C1 (de) * 1999-04-09 2001-01-11 Aventis Pharma Gmbh Mit Zuckerresten substituierte 1,4-Benzothiazepin-1,1-dioxidderivate, Verfahren zu deren Herstellung und deren Verwendung
DE60237594D1 (de) * 2001-04-25 2010-10-21 Takeda Pharmaceutical Verwendung des abc-expressionspromotors pioglitazon zur behandlung von arteriosklerose obliterans

Also Published As

Publication number Publication date
NO20041291D0 (no) 2004-03-26
US20040198788A1 (en) 2004-10-07
NZ531346A (en) 2005-10-28
MXPA04001878A (es) 2004-06-15
AU2002328569B9 (en) 2005-10-27
RU2004105965A (ru) 2005-05-10
CA2459017A1 (en) 2003-03-13
IL160438A0 (en) 2004-07-25
PL368843A1 (en) 2005-04-04
AU2002328569B2 (en) 2005-09-22
KR20040032969A (ko) 2004-04-17
NO20041291L (no) 2004-05-27
WO2003020315A1 (fr) 2003-03-13
CN1589154A (zh) 2005-03-02
BR0212254A (pt) 2004-10-19
ZA200401603B (en) 2004-10-19
EP1421953A4 (en) 2004-09-15
EP1421953A1 (en) 2004-05-26
CO5560583A2 (es) 2005-09-30

Similar Documents

Publication Publication Date Title
EA200301165A1 (ru) Лекарственное средство на основе оксикодона
UA90858C2 (ru) Композиция с контролируемым высвобождением варденафила
GB0211649D0 (en) Organic compounds
HUP0402217A2 (hu) Platinaszármazékot tartalmazó gyógyászati készítmények
IS6892A (is) Lyfjasamsetningar, skammtaform og aðferðir til aðgefa epóþílon um munn
ATE432689T1 (de) Arzneimittelformulierungen mit verzögerter freisetzung mit einem trägerpeptid
ATE298324T1 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
CY1112376T1 (el) Παραγωγα 2,3,4,9-τετραϋδρο-1η-καρβαζολης ως ανταγωνιστες του υποδοχεα crth2
TW200603787A (en) Topical preparations containing ambroxol
HUP0101411A2 (hu) 2-es típusú angiotenzin II receptor agonistákat tartalmazó gyógyszerkészítmények és ezek alkalmazása
CY1113894T1 (el) Φαρμακευτικη συνθεση που περιλαμβανει ροφλουμιλαστη και λεβοκετιριζινη
CY1107203T1 (el) Χρηση αναστολεων της il - 18 για τη θεραπεια και/ή την προληψη καρδιακης νοσου
RU2006131553A (ru) Комбинация(а) ингибитора топоизомеразы днк и (б) ингибитора iap
ATE499939T1 (de) Neue pharmazeutische zusammenstezungen, flibanserin polymorph a enthaltend
HUP0400553A2 (hu) Gyógyászati készítmények
HUP0402304A2 (hu) Deutériummal helyettesített dihidrofuranonszármazékok és azokat tartalmazó gyógyszerkészítmények
BRPI0412430A (pt) polipeptìdeo agonista do receptor de zot e zonulina
HUP0401696A2 (hu) Angiotenzin-II receptor antagonistát tartalmazó gyógyászati készítmény
CA2450915A1 (en) Use of levosimendan and beta-adrenergic receptor antagonist for the treatment of heart failure
TR200301553A1 (tr) İrbesartan etken maddesi içeren yeni oral farmasötik formülasyonlar
TW200501967A (en) Nemorubicin for use in the preparation of a medicament for liver disease
DE60327249D1 (de) Anthranilsäureamide und ihre pharmazeutische verwendung
TR200301552A1 (tr) Rofekoksib' in yeni oral farmakolojik formülasyonları.
HUP0300032A2 (en) Use of compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoreceptor for preparation of pharmaceutical composition
TH51665A (th) ยาเวชภัณฑ์

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees